Literature DB >> 10963786

Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor.

B Shenkman1, N Savion, R Dardik, I Tamarin, D Varon.   

Abstract

Recently, we described a method of testing platelet deposition on extracellular matrix under flow conditions. The method was used for assessment of platelet function in various platelet disorders, for monitoring of replacement and anti-platelet therapy. In the present study, we investigated platelet deposition on a polystyrene surface compared with that on extracellular matrix, under defined shear rates, using the original Cone and Plate(let) Analyzer. A correlation of adhesion rate (surface coverage) and aggregate formation (average size) of platelets from normal citrated blood between polystyrene and extracellular matrix was observed. Blocking of von Willebrand factor binding to glycoprotein Ib by a recombinant von Willebrand factor fragment substantially decreased platelet adhesion to both surfaces. Blocking of GPIIb-IIIa by Arg-Gly-Asp-Ser peptide prevented platelet adhesion to the polystyrene while an extensive adhesion of single platelets to extracellular matrix was observed. Furthermore, platelet adhesion to polystyrene but not to extracellular matrix was completely inhibited by platelet inactivation with prostaglandin E(1). Platelets from patients with severe von Willebrand disease yielded very low adhesion to both polystyrene and extracellular matrix. The addition of von Willebrand factor to the blood of these patients or pre-coating of polystyrene surface with von Willebrand factor restored the ability of platelets to adhere and aggregate on the surface. Platelets from patients with Glanzmann's thrombasthenia and afibrinogenemia adhered to extracellular matrix (with defective aggregate formation), while they failed to adhere to the polystyrene. Fibrinogen added to afibrinogenemia blood or pre-coating of the polystyrene with fibrinogen restored the ability of platelets to adhere and aggregate on the surface. In conclusion, the polystyrene surface, like extracellular matrix, can be used to assess platelet function disorders taking in account that platelet deposition on polystyrene under flow is absolutely dependent on platelet activation and on the presence of fibrinogen, von Willebrand factor, and their receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963786     DOI: 10.1016/s0049-3848(00)00255-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  16 in total

1.  Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants.

Authors:  N Linder; B Shenkman; E Levin; L Sirota; T H Vishne; I Tamarin; R Dardik; D Lubin; N Savion; D Varon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

2.  Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates.

Authors:  Carolina Caballo; Gines Escolar; Maribel Diaz-Ricart; Irene Lopez-Vílchez; Miguel Lozano; Joan Cid; Marcos Pino; Joan Beltrán; Misericordia Basora; Arturo Pereira; Ana M Galan
Journal:  Blood Transfus       Date:  2012-09-19       Impact factor: 3.443

3.  The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers.

Authors:  Noa Zemer-Wassercug; Moti Haim; Dorit Leshem-Lev; Katia L Orvin; Muthiah Vaduganathan; Ariel Gutstein; Ehud Kadmon; Aviv Mager; Ran Kornowski; Eli I Lev; Eli L Lev
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

4.  gC1qR/p33 blockade reduces Staphylococcus aureus colonization of target tissues in an animal model of infective endocarditis.

Authors:  Ellinor I B Peerschke; Arnold S Bayer; Berhane Ghebrehiwet; Yan Q Xiong
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

Review 5.  PLATELET FUNCTION IN TRAUMA: IS CURRENT TECHNOLOGY IN FUNCTION TESTING MISSING THE MARK IN INJURED PATIENTS?

Authors:  Jacob B Schriner; Mitchell J George; Jessica C Cardenas; Scott D Olson; Kimberly A Mankiewicz; Charles S Cox; Brijesh S Gill; Charles E Wade
Journal:  Shock       Date:  2022-07-19       Impact factor: 3.533

6.  Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.

Authors:  V H Flood; K D Friedman; J C Gill; P A Morateck; J S Wren; J P Scott; R R Montgomery
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

7.  Assays of different aspects of haemostasis - what do they measure?

Authors:  Nahreen Tynngård; Tomas L Lindahl; Sofia Ramström
Journal:  Thromb J       Date:  2015-02-05

8.  Role of sodium tungstate as a potential antiplatelet agent.

Authors:  Rebeca Fernández-Ruiz; Marc Pino; Begoña Hurtado; Pablo García de Frutos; Carolina Caballo; Ginés Escolar; Ramón Gomis; Maribel Diaz-Ricart
Journal:  Drug Des Devel Ther       Date:  2015-05-26       Impact factor: 4.162

9.  Age-Dependent Control of Collagen-Dependent Platelet Responses by Thrombospondin-1-Comparative Analysis of Platelets from Neonates, Children, Adolescents, and Adults.

Authors:  Katrin Herken; Martin Glauner; Stefanie C Robert; Matthias Maas; Sonja Zippel; Ulrike Nowak-Göttl; Barbara Zieger; Judith Lahav; Anke C Fender; Kerstin Jurk; Beate E Kehrel
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction.

Authors:  Reinhard Schneppenheim; Natalie Hellermann; Maria A Brehm; Ulrike Klemm; Tobias Obser; Volker Huck; Stefan W Schneider; Cécile V Denis; Alexander Tischer; Matthew Auton; Winfried März; Emma-Ruoqi Xu; Matthias Wilmanns; Rainer B Zotz
Journal:  Blood       Date:  2018-10-26       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.